Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Dr. Chantharavady Choulamany Wins 5th Annual Dr. Guislain "Breaking the Chains of Stigma" Award for Her Work to Address Mental Health Needs in Laos


News provided by

Dr. Guislain Museum

10 Oct, 2016, 19:20 GMT

Share this article

Share toX

Share this article

Share toX

Honor Celebrates Exceptional Contributions Made in the Field of Mental Health Advocacy and Awareness

NEW YORK, Oct. 10, 2016 /PRNewswire/ -- Today the Dr. Guislain Museum and Janssen Research & Development, LLC ("Janssen") named Chantharavady Choulamany, M.D., the 2016 recipient of the Dr. Guislain "Breaking the Chains of Stigma" Award. The award recognizes Laotian psychiatrist, Dr. Choulamany, for her impact on the quality of life for individuals who are living with mental illness. Dr. Choulamany will be recognized for her contributions at a special award event later today in New York.  As only one of two qualified psychiatrists in Lao People's Democratic Republic (PDR), a country of more than 6 million people. Dr. Choulamany has dedicated her life to increasing access to mental health services and developing education programs to treat and improve understanding of mental illness.

Dr. Choulamany has worked to address mental health issues and needs in her country with a uniquely successful approach. She works with all levels of government, advocating for better treatment services, more funding and pushing for more trained health professionals. Several of the 17 district and 7 provincial hospitals have now set up mental health teams, comprising of a doctor and two nurses, who have participated in a four-day mental health training program from BasicNeeds. To further overcome the shortage of trained health workers, Dr. Choulamany has enlisted the help of cultural groups to raise awareness of mental illness and to fight stigma. She has also provided training to Buddhist monks to help care for people with mental illness through counseling and prayer. More than 8,000 patients and family members have already benefited directly from Dr. Choulamany's work.

"Dr. Choulamany's work is changing the way an entire country thinks about and responds to mental illness. Her work is transforming the conversation about mental illness while increasing the level of understanding that individuals possess about this subject," said Brother René Stockman, General Director of the Dr. Guislain Museum. "Our organization is pleased to provide this award in honor of her unique contributions."

Each year, the Dr. Guislain Award receives nominations from mental health professionals across the globe. Dr. Choulamany was selected from more than 55 nominees by a jury of international mental health advocates and renowned authorities in the field.

In addition to her current role as Program Manager in her country for BasicNeeds, an international, non-governmental, mental-health focused organization, Dr. Choulamany, with strong government support, oversees a number of national and local initiatives, all with the goal of treating mental illness and reducing the stigma associated with it. Dr. Choulamany was one of the co-authors of the 2002 report commissioned by the World Health Organization (WHO) that analyzed the mental health issues in Lao PDR and more recently has been involved in drafting "A National Strategy for Mental Health by 2020" in conjunction with the WHO.

"My work has been challenging, yet rewarding. When you are able to assist one person in living a happier, fuller life, you are helping them, their family and their entire community," said Dr. Choulamany. "There is still much work to be done, but the progress that we have made through education and making treatment more accessible is something in which I take great pride."

Earlier in her career, Dr. Choulamany worked at the University of Medicine in Vientiane, Lao PDR, then the Mahosot Hospital, under the Ministry of Health. While at the University of Medicine, Dr. Choulamany taught psychiatry and mental health, as well as developed French language e-learning information in general psychiatry under the Francophone Cooperation Framework for medical students in 2008.

"Dr. Choulamany's efforts demonstrate how one individual can make a difference in raising awareness of mental health issues and fighting stigma," said Husseini K. Manji, MD, Global Therapeutic Area Head for Neuroscience, Janssen Research & Development, LLC. "Each year, Janssen seeks to recognize deserving individuals for their work to reduce mental health stigma in communities around the world. Dr. Choulamany's work is especially commendable and has an impact on countless lives throughout her country."

The Dr. Guislain "Breaking the Chains of Stigma" Award was created in 2011 to honor the legacy of Dr. Joseph Guislain (1797-1860), the first Belgian psychiatrist to provide scientifically based treatment for patients with mental illness and a staunch patient advocate. Both the Dr. Guislain Museum and Janssen share a rich heritage and long-standing involvement in the field of mental illness research, treatment and education. For nearly 30 years, the Museum has dedicated itself to educate the public and rectify the misunderstandings and prejudice associated with treatment for mental illness.

The Dr. Guislain Award program is a joint project of the Dr. Guislain Museum and Janssen Research & Development, LLC. Janssen provides financial and in-kind support for the program.  Dr. Choulamany will receive a $50,000 prize that must be used toward further work to reduce societal stigma about mental health and disorders of the brain.

Janssen's sponsorship of this award reflects its more than 50-year commitment to help find solutions for patients with mental illness. An important component of the Healthy Minds initiative of the Janssen Pharmaceutical Companies of Johnson & Johnson, the award aims to encourage collaboration among biotechnology, pharmaceutical and public-sector partners to accelerate the discovery of new therapeutic solutions for diseases and disorders of the brain, as well as support the mental health community and various advocacy organizations and projects.

About the Dr. Guislain "Breaking the Chains of Stigma" Award

Individuals, organizations or projects all over the world that have made an exceptional contribution in dealing with, or promoting the awareness of, mental health care are eligible to receive the Dr. Guislain "Breaking the Chains of Stigma" Award. The Award is given to an individual(s), organization or project that:

  • has made an exceptional contribution to mental health care in the broadest sense on a cultural and/or social level;
  • has provided a genuine contribution to decreasing stigma around mental health conditions;
  • has promoted attention for mental health care; and
  • has done all this with passion, creativity and innovation.

The jury is comprised of:

  • Mohan Agashe – Actor, psychiatrist, member of Governing and Executive Council at Children Film Society of India
  • Ellen Baxter – Housing advisory, social justice leader and founder of the Broadway Housing Communities in New York City
  • Siri Hustvedt – Essayist, novelist and poet
  • Vikram Patel – Professor of International Mental Health and Wellcome Trust Senior Research Fellow in Clinical Science at the London School of Hygiene & Tropical Medicine, co-director of the Public Health Foundation of India's Centre for Chronic Conditions and Injuries, co-founder of Sangat and fellow of the Academy of Medical Sciences
  • Dr. Bernard Sabbe – Professor of medical psychology and psychiatry at University of Antwerp and Vrije Universiteit Brussel, and psychiatrist/psychotherapist at Sint-Norbertus Psychiatric Hospital in Duffel
  • Erik Thys – Psychiatrist in the University Psychiatric Centre at the KU Leuven in Kortenberg and the Psycho-Social Centre St. Alexius Ixelles in Brussels

About the Dr. Guislain Museum

The Dr. Guislain Museum was founded in 1986 in Ghent, Belgium, and its exhibits address the history of psychiatry in a permanent collection and through a series of half-yearly changing thematic exhibitions. The Museum features an array of psychiatric photographs, two centuries of comprehensive archives and an extensive library chronicling the history of psychiatry. Comprehensively, the Museum seeks to educate the public and rectify the misunderstandings and prejudice associated with treatment for mental illness. The Dr. Guislain Museum attracts 70,000 visitors each year.

About Dr. Joseph Guislain

Dr. Joseph Guislain (1797-1860) was a driven activist for patients with mental illness and the first Belgian psychiatrist to provide scientifically-based treatment for these individuals. As a passionate advocate for those with mental illness, Dr. Guislain worked tirelessly to stand up for the rights of patients and help improve their social position. He lectured and published extensively about mental illness and enjoyed considerable recognition by his contemporaries.

For more information, about the Dr. Guislain Award, please visit www.drguislainaward.org.

*Employees and officers of Johnson & Johnson, Janssen Research & Development, LLC, and their respective affiliates, subsidiaries, The Dr. Guislain Museum, any promotional agencies and members of the immediate family or household of each, are not eligible to participate in the Dr. Guislain Award as nominators, Award candidates or judges. Immediate family member is defined as a parent, sibling or any person residing in the same household as the employee.

Contact:
Patrick Allegaert
Dr. Guislain Museum
+32 9 216 35 95
allegaert.patrick@gmail.com

Yoon Hee Lamot
Dr. Guislain Museum
+32 9 216 35 36
y.lamot@museumdrguislain.be

Related Links

http://www.drguislainaward.org/

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.